News Stocks 

Proteostasis’s stock rockets on heavy volume after BTD granted

“Volume topped 14 million shares, compared with the full-day average over the past 30 days of about 780,000 shares, according to FactSet” writes Reporter Editor for Despite Tuesday’s rally, the stock has still shed 45% over the past 12 months, while the iShares Nasdaq Biotechnology ETF IBB, +0.58% has climbed 15% and the S&P 500 SPX, +0.53% has gained 18%.

Share This:

Related posts